Home Home News Rare Disorders FDA Approves Bylvay (Odevixibat) as a Breakthrough Treatment for Cholestatic Pruritus in Alagille Syndrome Patients 1 year ago Mona Al Absi Alagille syndrome (ALGS) is a rare genetic disorder that affects around one in every 30,000 live births. It results from...